Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Judge

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Clinical Investigation|October 23, 1997
Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transferH Zhang, Y Yang, J L Horton, et al.
Nature Medicine|September 30, 1999
Tissue-specific consequences of the anti-adenoviral immune response: implications for cardiac transplantsS Y Chan, K Li, J R Piccotti, et al.
Transplantation|September 12, 1998
Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survivalT A Judge, N M Desai, Z Yang, et al.
The American Journal of Gastroenterology|January 5, 2002
An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitisJ D Lewis, G R Lichtenstein, R B Stein, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Clinical Investigation|October 23, 1997
Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transferH Zhang, Y Yang, J L Horton, et al.
Nature Medicine|September 30, 1999
Tissue-specific consequences of the anti-adenoviral immune response: implications for cardiac transplantsS Y Chan, K Li, J R Piccotti, et al.
Transplantation|September 12, 1998
Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survivalT A Judge, N M Desai, Z Yang, et al.
The American Journal of Gastroenterology|January 5, 2002
An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitisJ D Lewis, G R Lichtenstein, R B Stein, et al.
Pageof 3